Skip to main content

Table 2 Descriptive statistics of distributions of tumor characteristics comparing interval cancers to screen-detected cancers, interval cancers to screen-detected cancers limited to nondense breasts and interval cancers to screen-detected cancers limited to dense breasts

From: Mammographic density and survival in interval breast cancers

 

All (n= 1,400)

Nondense, PD <25% (n= 1,055)

Dense, PD ≥25% (n= 345)

 

SD cancer

(n= 1,115)

IC

(n= 285)

Pvalue

SD cancer

(n= 867)

IC

(n= 188)

Pvalue

SD cancer

(n= 248)

IC

(n= 97)

Pvalue

Mean tumor size (mm)

14.4

20.5

<0.001

14.2

19.6

<0.001

15.2

22.4

<0.001

Lymph node metastasis, n (%)

  

<0.001

  

<0.001

  

0.001

   Positive

240 (22%)

109 (39%)

 

190 (22%)

72 (39%)

 

50 (20%)

37 (38%)

 

   Negative

856 (78%)

171 (61%)

 

660 (78%)

111 (61%)

 

196 (80%)

60 (62%)

 

ER status, n (%)

  

0.020

  

0.054

  

0.150

   Positive

627 (83%)

162 (76%)

 

492 (82%)

99 (75%)

 

135 (84%)

63 (77%)

 

   Negative

131 (17%)

52 (24%)

 

106 (18%)

33 (25%)

 

25 (16%)

19 (23%)

 

PR status, n (%)

  

0.008

  

0.018

  

0.133

   Positive

536 (72%)

130 (62%)

 

420 (71%)

78 (60%)

 

116 (74%)

52 (65%)

 

   Negative

211 (28%)

79 (38%)

 

171 (29%)

51 (40%)

 

40 (26%)

28 (35%)

 

Grade, n (%)

  

<0.001

  

0.008

  

0.012

   1

147 (20%)

20 (11%)

 

116 (20%)

15 (14%)

 

31 (19%)

5 (6%)

 

   2

333 (45%)

71 (37%)

 

265 (45%)

40 (36%)

 

68 (42%)

31 (39%)

 

   3

268 (36%)

99 (52%)

 

205 (35%)

56 (50%)

 

63 (39%)

43 (54%)

 

Histological classification, n (%)

  

0.703

  

0.872

  

0.441

   Ductal

813 (73%)

206 (74%)

 

640 (74%)

134 (72%)

 

173 (71%)

72 (76%)

 

   Lobular

125 (11%)

35 (13%)

 

92 (11%)

22 (12%)

 

33 (13%)

13 (14%)

 

   Other

173 (16%)

39 (14%)

 

134 (15%)

29 (16%)

 

39 (16%)

10 (11%)

 

Proliferation rate

  

<0.001

  

<0.001

  

0.523

   High

108 (25%)

52 (42%)

 

83 (25%)

36 (48%)

 

25 (28%)

16 (33%)

 

   Low

316 (75%)

71 (58%)

 

252 (75%)

39 (52%)

 

64 (72%)

32 (67%)

 
  1. aIC, interval cancer; ER, estrogen receptor; PD, percentage density; PR, progesterone receptor; SD, screen-detected.